Perspectives, fears and expectations of patients with gynaecological cancers during the COVID-19 pandemic: A Pan-European study of the European Network of Gynaecological Cancer Advocacy Groups (ENGAGe).
COVID-19
EU
anxiety
cancer
depression
expectation
gynaecologic oncology
patients
perspectives
Journal
Cancer medicine
ISSN: 2045-7634
Titre abrégé: Cancer Med
Pays: United States
ID NLM: 101595310
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
21
09
2020
revised:
14
10
2020
accepted:
23
10
2020
pubmed:
19
11
2020
medline:
9
2
2021
entrez:
18
11
2020
Statut:
ppublish
Résumé
The impact of the COVID-19 pandemic on European gynaecological cancer patients under active treatment or follow-up has not been documented. We sought to capture the patient perceptions of the COVID-19 implications and the worldwide imposed treatment modifications. A patient survey was conducted in 16 European countries, using a new COVID-19-related questionnaire, developed by ENGAGe and the Hospital Anxiety & Depression Scale questionnaire (HADS). The survey was promoted by national patient advocacy groups and charitable organisations. We collected 1388 forms; 592 online and 796 hard-copy (May, 2020). We excluded 137 due to missing data. Median patients' age was 55 years (range: 18-89), 54.7% had ovarian cancer and 15.5% were preoperative. Even though 73.2% of patients named cancer as a risk factor for COVID-19, only 17.5% were more afraid of COVID-19 than their cancer condition, with advanced age (>70 years) as the only significant risk factor for that. Overall, 71% were concerned about cancer progression if their treatment/follow-up was cancelled/postponed. Most patients (64%) had their care continued as planned, but 72.3% (n = 892) said that they received no information around overall COVID-19 infection rates of patients and staff, testing or measures taken in their treating hospital. Mean HADS Anxiety and Depression Scores were 8.8 (range: 5.3-12) and 8.1 (range: 3.8-13.4), respectively. Multivariate analysis identified high HADS-depression scores, having experienced modifications of care due to the pandemic and concern about not being able to visit their doctor as independent predictors of patients' anxiety. Gynaecological cancer patients expressed significant anxiety about progression of their disease due to modifications of care related to the COVID-19 pandemic and wished to pursue their treatment as planned despite the associated risks. Healthcare professionals should take this into consideration when making decisions that impact patients care in times of crisis and to develop initiatives to improve patients' communication and education.
Sections du résumé
BACKGROUND
The impact of the COVID-19 pandemic on European gynaecological cancer patients under active treatment or follow-up has not been documented. We sought to capture the patient perceptions of the COVID-19 implications and the worldwide imposed treatment modifications.
METHODS
A patient survey was conducted in 16 European countries, using a new COVID-19-related questionnaire, developed by ENGAGe and the Hospital Anxiety & Depression Scale questionnaire (HADS). The survey was promoted by national patient advocacy groups and charitable organisations.
FINDINGS
We collected 1388 forms; 592 online and 796 hard-copy (May, 2020). We excluded 137 due to missing data. Median patients' age was 55 years (range: 18-89), 54.7% had ovarian cancer and 15.5% were preoperative. Even though 73.2% of patients named cancer as a risk factor for COVID-19, only 17.5% were more afraid of COVID-19 than their cancer condition, with advanced age (>70 years) as the only significant risk factor for that. Overall, 71% were concerned about cancer progression if their treatment/follow-up was cancelled/postponed. Most patients (64%) had their care continued as planned, but 72.3% (n = 892) said that they received no information around overall COVID-19 infection rates of patients and staff, testing or measures taken in their treating hospital. Mean HADS Anxiety and Depression Scores were 8.8 (range: 5.3-12) and 8.1 (range: 3.8-13.4), respectively. Multivariate analysis identified high HADS-depression scores, having experienced modifications of care due to the pandemic and concern about not being able to visit their doctor as independent predictors of patients' anxiety.
INTERPRETATION
Gynaecological cancer patients expressed significant anxiety about progression of their disease due to modifications of care related to the COVID-19 pandemic and wished to pursue their treatment as planned despite the associated risks. Healthcare professionals should take this into consideration when making decisions that impact patients care in times of crisis and to develop initiatives to improve patients' communication and education.
Identifiants
pubmed: 33205595
doi: 10.1002/cam4.3605
pmc: PMC7753798
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
208-219Informations de copyright
© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Références
Ann Oncol. 2020 Aug;31(8):1065-1074
pubmed: 32442581
Lancet. 2020 Jul 4;396(10243):27-38
pubmed: 32479829
Front Psychol. 2020 Aug 24;11:2033
pubmed: 32982846
J Gynecol Oncol. 2020 Jul;31(4):e68
pubmed: 32458596
J Visc Surg. 2020 Jun;157(3S1):S25-S31
pubmed: 32387058
BMJ. 2017 Jan 25;356:j108
pubmed: 28122812
J Geriatr Oncol. 2020 Sep;11(7):1175-1181
pubmed: 32402764
Br J Surg. 2020 Oct;107(11):1440-1449
pubmed: 32395848
Int J Gynecol Cancer. 2020 May;30(5):561-563
pubmed: 32221023
Lancet Oncol. 2020 Mar;21(3):335-337
pubmed: 32066541
Target Oncol. 2020 Jun;15(3):249-259
pubmed: 32445083
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Lancet Oncol. 2020 Apr;21(4):e180
pubmed: 32142622
Health Qual Life Outcomes. 2003 Aug 01;1:29
pubmed: 12914662
ESMO Open. 2020 May;5(Suppl 3):
pubmed: 32457036
Int J Gynecol Cancer. 2010 Jan;20(1):34-40
pubmed: 20130501